Appeal Dismissed: Emphasis on Scientific Research Deductions

The Court dismissed the appeal filed by the Revenue under Section 260A of the Income Tax Act, 1961 against the order of the Income Tax Appellate Tribunal. The Court rejected the questions raised by the Revenue concerning R&D expenditure and weighted deduction under section 35(2AB), emphasizing the importance of encouraging scientific research, particularly in clinical trials for pharmaceutical development. The Court concluded that the Tribunal's decision was sound, highlighting the need for a broad interpretation of scientific research for claiming deductions under the Act.

---

---

Issues:
1. Appeal filed under Section 260A of the Income Tax Act, 1961 against the order of the Income Tax Appellate Tribunal.
2. Questions of law proposed by the Revenue regarding R&D expenditure and weighted deduction under sections 35(2AB).
3. Admittance and rejection of questions 2(a) and 2(b) by the Court.

Analysis:
1. The appeal was filed by the Revenue under Section 260A of the Income Tax Act, 1961 against the order of the Income Tax Appellate Tribunal, Ahmedabad dated 20th June 2019 for the Assessment Year 2008-09.
2. The Revenue raised substantial questions of law concerning the disallowance of R&D expenditure and weighted deduction under section 35(2AB). The Court rejected question 2(a) based on a previous decision in the assessee's case, emphasizing that the issue was fact-based and did not raise any legal question.
3. Regarding question 2(b), the Court referred to the case of Commissioner of Income-tax vs. Cadila Healthcare Ltd and highlighted the importance of encouraging scientific research, especially in clinical trials. The Court emphasized that clinical trials may not always be conducted in an in-house facility, and such trials are essential for the development of pharmaceutical drugs. The Court cited previous judgments to support the broad interpretation of scientific research for claiming deductions under section 35(2AB).
4. Consequently, the Court rejected question 2(b) as well, concluding that the Tribunal did not commit any error in its decision. The appeal was dismissed, affirming the decisions on both questions raised by the Revenue.

This detailed analysis of the judgment provides insights into the legal issues raised by the Revenue, the Court's reasoning behind the rejection of the questions, and the broader interpretation of scientific research for claiming deductions under the Income Tax Act.

---